Endurant Capital Management LP Astrazeneca PLC Transaction History

Endurant Capital Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $2.55 Million - $2.76 Million	-36,449 Reduced 37.48%	60,808 $4.35 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $2.79 Million - $3.16 Million	-44,163 Reduced 31.23%	97,257 $6.75 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $2.19 Million - $2.84 Million	40,372 Added 39.95%	141,420 $9.59 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $5.36 Million - $13.7 Million	101,048 New	101,048 $5.54 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $14.2 Million - $17.1 Million	-240,271 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $4.71 Million - $5.67 Million	-84,457 Reduced 26.01%	240,271 $15.9 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $17.5 Million - $20.7 Million	324,728 New	324,728 $18.9 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $11.5 Million - $14.3 Million	-238,099 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $8.55 Million - $9.86 Million	181,208 Added 318.52%	238,099 $11.8 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $2.76 Million - $3.3 Million	56,891 New	56,891 $2.84 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $1.32 Million - $1.57 Million	-31,031 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $3.76 Million - $4.27 Million	-93,828 Reduced 75.15%	31,031 $1.38 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $4.65 Million - $5.2 Million	124,859 New	124,859 $5.15 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.